AMERICAN EXPRESS CO
DEFA14A, 1997-03-11
FINANCE SERVICES
Previous: ALUMINUM CO OF AMERICA, 10-K, 1997-03-11
Next: AMERICAN EXPRESS CO, DEF 14A, 1997-03-11



<PAGE>
<PAGE>
                        Securities and Exchange Commission
                              Washington, D.C. 20549
                        ----------------------------------

                            Schedule 14A Information

Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934
                                (Amendment No. )

Filed by the Registrant [X]
Filed by a Party other than the Registrant[ ]
Check the appropriate box:
[ ] Preliminary Proxy Statement
[ ] Confidential, for Use of the Commission Only (as permitted by 
    Rule 14a-6(e)(2))
[ ] Definitive  Proxy  Statement
[X] Definitive Additional  Materials
[ ] Soliciting Material Pursuant to Section 240.14a-11(c) or Section 240.14a-12

                            American Express Company
                (Name of Registrant as Specified In Its Charter)

- -------------------------------------------------------------------------------
       (Name of Person(s) Filing Proxy Statement if other than Registrant)

Payment of Filing Fee (Check the appropriate box):
[X] No fee required
    Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.

      1) Title of each class of securities to which transaction applies:

      2) Aggregate number of securities to which transaction applies:

      3) Per unit price or other underlying value of transaction computed
         pursuant to Exchange Act Rule 0-11 (Set forth the amount on which
         the filing fee is calculated and state how it was determined):

      4) Proposed maximum aggregate value of transaction:

      5) Total fee paid:

[ ] Fee paid previously with preliminary materials.
[ ] Check box if any part of the fee is offset as provided by Exchange Act
    Rule 0-11(a)(2) and identify the filing for which the offsetting fee was
    paid previously.  Identify the previous filing by registration statement
    number, or the Form or Schedule and the date of its filing.

     1) Amount Previously Paid:

     2) Form, Schedule or Registration Statement No.:

     3) Filing Party:

     4) Date Filed:

<PAGE>
<PAGE>
       SMITHKLINE BEECHAM CHIEF EXECUTIVE NOMINATED TO 
          AMERICAN EXPRESS COMPANY BOARD OF DIRECTORS

NEW YORK -- March 11, 1997 -- American Express Company announced today that
Jan Leschly, Chief Executive of SmithKline Beecham, has been nominated for
election to the American Express Board of Directors at the company's upcoming
Annual Shareholders Meeting. 

     Leschly has been Chief Executive of SmithKline Beecham, one of the
world's leading healthcare companies, since 1994.  He joined SmithKline
Beecham as chairman of the pharmaceutical division in 1990, having previously
served as President and Chief Operating Officer of Squibb Corporation.  Prior
to joining Squibb in 1979, he was with Novo Nordisk, a Danish pharmaceutical
company, where he served as Executive Vice President and President of the
pharmaceuticals division.       

     "Jan is an outstanding executive whose broad knowledge of international
markets and business judgment will make him a strong addition to our Board,"
said Harvey Golub, Chairman and Chief Executive Officer of American Express
Company.    

     Leschly is highly regarded within the healthcare industry.  In 1995, he
was named one of Business Week's top 25 managers and received the 1995
Pharmacy Practitioner of the Year Award from the International Pharmaceutical
Federation  Foundation for Education and Research.  He is active in a number of
professional healthcare organizations, including serving on the Board of the
Pharmaceutical Research and Manufacturers of America.  Leschly was born in
Denmark and received his bachelor's degree in Pharmacy from Copenhagen
College and in business administration from the Copenhagen School of
Economics and Business Administration.


<PAGE>
<PAGE>
     Outside of the healthcare industry, Leschly has been well known in
professional tennis circles.  He was ranked 10th in the world in 1965 and
played in 16 consecutive Wimbledon tournaments. 

     Last week, American Express announced that Ken Chenault, newly elected
President and Chief Operating Officer of the company, has also been nominated
to serve on the Board of Directors.  Twelve current directors are standing
for re-election.  They are Daniel F. Akerson; Anne L. Armstrong; Edwin L.
Artzt; William G. Bowen; Charles W. Duncan, Jr.; Beverly Sills Greenough; F.
Ross Johnson; Vernon E. Jordan, Jr.; Drew Lewis; Aldo Papone; Frank P.
Popoff; and Harvey Golub.  David M. Culver, who has reached the Board's
mandatory retirement age of 72, is not standing for re-election.  

     The company's Annual Meeting of Shareholders is scheduled for April 28.

     American Express Company is a global travel, financial and network
services provider founded in 1850.  It is a leader in charge and credit
cards, Travelers Cheques, travel, financial planning, investment products,
insurance, accounting and international banking.
<PAGE>



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission